Drug-related problems in patients with rheumatoid arthritis

References

• FleischmannRKremerJCushJPlacebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritisN Engl J Med2012367649550722873530
   PubMed Web of Science ®Google Scholar
• KnevelRHuizingaTWJKurreemanFGenomic influences on susceptibility and severity of rheumatoid arthritisRheum Dis Clin North Am201743334736128711138
   PubMed Web of Science ®Google Scholar
• RudanISidhuSPapanaAPrevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysisJ Glob Health20155101040925969732
   PubMed Web of Science ®Google Scholar
• GibofskyAEpidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsisAm J Manag Care2014207 SupplS128S13525180621
   PubMed Web of Science ®Google Scholar
• BrunierLBleterryMMerleSPrevalence of rheumatoid arthritis in the French West Indies: results of the EPPPRA study in MartiniqueJoint Bone Spine201784445546127825567
   PubMed Web of Science ®Google Scholar
• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Rheumatoid arthritis2014 Available from: https://storage.googleapis.com/quantumunitsed-com/materials/1700_What-is-Rheumatoid-Arthritis.pdfAccessed December 21, 2017
   Google Scholar
• CojocaruMImCSilosiIVrabieCDTanasescuRExtra-articular manifestations in rheumatoid arthritisMædica201054286291
   PubMedGoogle Scholar
• BurmesterGRPopeJENovel treatment strategies in rheumatoid arthritisLancet2017389100862338234828612748
   PubMed Web of Science ®Google Scholar
• DougadosMSoubrierMAntunezAPrevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)Ann Rheum Dis2014731626824095940
   PubMed Web of Science ®Google Scholar
• LiaoKPCardiovascular disease in patients with rheumatoid arthritisTrends Cardiovasc Med201727213614027612551
   PubMed Web of Science ®Google Scholar
• MichaudKWolfeFComorbidities in rheumatoid arthritisBest Pract Res Clin Rheumatol200721588590617870034
   PubMed Web of Science ®Google Scholar
• JeongHBaekSYKimSWComorbidities of rheumatoid arthritis: results from the Korean national Health and Nutrition Examination SurveyPLoS One2017124e017626028423031
   PubMed Web of Science ®Google Scholar
• RanganathVKMaranianPElashoffDAComorbidities are associated with poorer outcomes in community patients with rheumatoid arthritisRheumatology201352101809181723813577
   PubMed Web of Science ®Google Scholar
• Pharmaceutical Care Network Europe Foundation (PCNE)PCNE classification for drug related problems version 5.012006 Available from: http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V5.01.pdfAccessed December 18, 2017
   Google Scholar
• ErnstMEIyerSSDoucetteWRDrug-related problems and quality of life in arthritis and low back pain sufferersValue Health200361515812535238
   PubMed Web of Science ®Google Scholar
• TreharneGJDouglasKMIwaszkoJPolypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidityMusculoskeletal Care20075417519017623274
   PubMedGoogle Scholar
• HuriHZLingCFRazackAHDrug-related problems in patients with erectile dysfunctions and multiple comorbiditiesTher Clin Risk Manag20171340741928408836
   PubMed Web of Science ®Google Scholar
• Zaman HuriHHui XinCSulaimanCZDrug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective studyPLoS One201491e8621524475089
   PubMed Web of Science ®Google Scholar
• Zaman HuriHFun WeeHDrug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective studyBMC Endocr Disord201313223289895
   PubMed Web of Science ®Google Scholar
• StefanskiALTomiakCPleyerUDietrichTRüdiger BurmesterGDörnerTThe diagnosis and treatment of sjögren’s syndromeDeutsch Ärzteb Int201711420354361
   PubMed Web of Science ®Google Scholar
• HurnSEVicenzinoBTSmithMDNon-surgical treatment of hallux valgus: a current practice survey of Australian podiatristsJ Foot Ankle Res201691627148407
   PubMed Web of Science ®Google Scholar
• RicheldiLCollardHRJonesMGIdiopathic pulmonary fibrosisLancet2017389100821941195228365056
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Elderly population2018 Available from: http://www.who.int/healthinfo/survey/ageingdefnolder/enAccessed April 13, 2018
   Google Scholar
• CantlayAGlynTBartonNPolypharmacy in the elderlyInnovAiT2016926977
   Google Scholar
• International Society of nephrology (ISN)KDIGO clinical practice guideline for acute kidney injuryOfficial J Int Soc Nephrol201821115
   Google Scholar
• ChtiouiHBuclinTPharmacokinetics in hepatic impairment: mind the protein bindingJ Hepatol20156361539154026343957
   PubMed Web of Science ®Google Scholar
• InnalaLBerglinEMöllerBAge at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective studyArthritis Res Ther2014162R9424731866
   PubMed Web of Science ®Google Scholar
• CristinaSLucianPElviraCMariaSSex ratio and age in patients with rheumatoid arthritis: data from a cohort in south-east RomaniaRom J Rheumatol2015244220225
   Google Scholar
• AlmeidaMSAlmeidaJVBertoloMBDemographic and clinical features of patients with rheumatoid arthritis in Piauí, Brazil – evaluation of 98 patientsRev Bras Reumatol2014545360365 Portuguese25627299
   PubMedGoogle Scholar
• BrunelleschiSImmune response and auto-immune diseases: gender does matter and makes the differenceIJGSM201621514
   Google Scholar
• HajiabbasiAShenavar MasoolehIAlizadehYBanikarimiASGhavidel ParsaPSecondary Sjogren’s syndrome in 83 patients with rheumatoid arthritisActa Med Iran201654744845327424016
   PubMedGoogle Scholar
• AnteroDCParraAGMiyazakiFHGehlenMSkareTLSecondary Sjögren’s syndrome and disease activity of rheumatoid arthritisRev Assoc Med Bras201157331932221691696
   PubMed Web of Science ®Google Scholar
• VallejoAARutherfordaFilkovaMPolypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritisAnn Rheum Dis201776Suppl 2806
   Google Scholar
• FilkovaMCarvalhoJNortonSPolypharmacy and unplanned hospitalizations in patients with rheumatoid arthritisJ Rheumatol201744121786179328966210
   PubMed Web of Science ®Google Scholar
• Al-MalaqHMAl-ArfajHFAl-ArfajASAdverse drug reactions caused by methotrexate in Saudi populationSaudi Pharm J201220430130523960804
   PubMed Web of Science ®Google Scholar
• GilaniSTKhanDAKhanFAAhmedMAdverse effects of low dose methotrexate in rheumatoid arthritis patientsJ Coll Physicians Surg Pak201222210110422313647
   PubMed Web of Science ®Google Scholar
• DubeyLChatterjeeSGhoshAHepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: an observational studyIndian J Pharmacol201648559159427721549
   PubMed Web of Science ®Google Scholar
• LowCLowCCoughlanRJO’DonnellMJCareyJJRisk of liver injury among methotrexate users: a meta-analysis of randomised controlled trialsSemin Arthritis Rheum201545215616226088004
   PubMed Web of Science ®Google Scholar
• HeidariRRastiMShirazi YeganehBNiknahadHSaeediANajibiASulfasalazine-induced renal and hepatic injury in rats and the protective role of taurineBioimpacts2016613827340618
   PubMedGoogle Scholar
• RudermanEMOverview of safety of non-biologic and biologic DMARDsRheumatology201251Suppl 6vi37vi4323221586
   PubMed Web of Science ®Google Scholar
• HodkinsonBMagomeroKRTiklyMCombination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approachTher Adv Musculoskelet Dis20168517217927721903
   PubMed Web of Science ®Google Scholar
• LondonoJSantosAMSantosPICubidezMFGuzmanCValle-OñateRTherapeutic efficacy and safety of methotrexate + leflunomide in Colombian patients with active rheumatoid arthritis refractory to conventional treatmentRev Bras Reumatol201252683784523223695
   PubMedGoogle Scholar
• LouisBSTimothyMAmerican College of rheumatology guideline for the treatment of rheumatoid arthritisArthritis Care Res20166811252015
   Web of Science ®Google Scholar
• ChanDCChenJHWenCJChiuLSWuSCEffectiveness of the medication safety review clinics for older adults prescribed multiple medicationsJ Formos Med Assoc2014113210611324530244
   PubMed Web of Science ®Google Scholar
• EganBMLiJQanungoSWolfmanTEBlood pressure and cholesterol control in hypertensive hypercholesterolemic patients: NHANES 1988–2010Circulation20131281294123817481
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society (AGS)American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adultsJ Am Geriatr Soc2015604616631
   Google Scholar
• RambhadeSChakarbortyAShrivastavaAPatilUKRambhadeAA survey on polypharmacy and use of inappropriate medicationsToxicol Int2012191687322736907
   PubMedGoogle Scholar
• AhmadAMastMRNijpelsGEldersPJDekkerJMHugtenburgJGIdentification of drug-related problems of elderly patients discharged from hospitalPatient Prefer Adherence2014815516524523581
   PubMed Web of Science ®Google Scholar
• BrowningDJThe prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing bothAm J Ophthalmol2016166ixxi27133016
   PubMed Web of Science ®Google Scholar
• PauloseRChhablaniJJhinganMUpdate on hydroxychloroquine retinopathyKerala J Ophthalmol2017291913
   Google Scholar
• BelloAEPerkinsELJayREfthimiouPRecommendations for optimizing methotrexate treatment for patients with rheumatoid arthritisOpen Access Rheumatol20179677928435338
   PubMed Web of Science ®Google Scholar
• ĆalasanMBvan den BoschOFCreemersMCPrevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritisArthritis Res Ther2013156R21724345416
   PubMed Web of Science ®Google Scholar
• NairSCJacobsJWBakkerMFDetermining the lowest optimally effective methotrexate dose for individual RA patients using their dose response relation in a tight control treatment approachPLoS One2016113e014879126987073
   PubMed Web of Science ®Google Scholar
• HoblELMaderRMJilmaBA randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritisClin Ther20123451195120322516039
   PubMed Web of Science ®Google Scholar
• de CuyperEde GuchtVMaesSvan CampYde ClerckLSDeterminants of methotrexate adherence in rheumatoid arthritis patientsClin Rheumatol20163551335133926781783
   PubMed Web of Science ®Google Scholar
• MarengoMFSuarez-AlmazorMEImproving treatment adherence in patients with rheumatoid arthritis: what are the options?Int J Clin Rheumtol201510534535627087857
   PubMedGoogle Scholar
• JoplinSvan der ZwanRJoshuaFWongPKKMedication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasoundBiomed Res Int201520159110
   Web of Science ®Google Scholar
• PalleriaCDi PaoloAGiofrèCPharmacokinetic drug-drug interaction and their implication in clinical managementJ Res Med Sci201318760161024516494
   PubMed Web of Science ®Google Scholar
• PatanèMCiriacoMChimirriSInteractions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritisAdv Pharmacol Sci20132013718
   Google Scholar
• BagatiniFBlattCRMaliskaGPotential drug interactions in patients with rheumatoid arthritisRev Bras Reumatol20115112939
   Google Scholar
• HallJJBolinaMChatterleyTJamaliFInteraction between low-dose methotrexate and nonsteroidal anti-inflammatory drugs, penicillins, and proton pump inhibitorsAnn Pharmacother201751216317827701081
   PubMed Web of Science ®Google Scholar
• CuschieriKGrechLAquilinaDAssessing the awareness of rheumatoid arthritis patients on the occurrence of adverse drug reactions caused by methotrexateRheumatology201453Suppl 1i155
   Google Scholar
• Rheumatoid patient FoundationRheumatoid awareness day2013 Available from: http://rawarrior.com/first-awareness-day-for-rheumatoid-arthritis-established-by-rheumatoid-patient-foundationAccessed April 13, 2018
   Google Scholar
• PetersonCGustafssonMCharacterisation of drug-related problems and associated factors at a clinical pharmacist service-naïve hospital in northern SwedenDrugs Real World Outcomes2017429710728527149
   PubMedGoogle Scholar
• RamanathKNedumballiSAssessment of medication-related problems in geriatric patients of a rural tertiary care hospitalJ Young Pharm20124427327823492987
   PubMedGoogle Scholar
• KohYKuttyFBLiSCDrug-related problems in hospitalized patients on polypharmacy: the influence of age and genderTher Clin Risk Manag200511394818360542
   PubMedGoogle Scholar
• DivoMJMartinezCHManninoDMAgeing and the epidemiology of multimorbidityEur Respir J20144441055106825142482
   PubMed Web of Science ®Google Scholar
• FerrándezOGrauSUrbinaOMojalSRiuMSalasEValidation of a score to identify inpatients at risk of a drug-related problem during a 4-year periodSaudi Pharm J201826570370829991914
   PubMed Web of Science ®Google Scholar
• LampropoulosCEOrfanosPBourniaVKAdverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world studyClin Exp Rheumatol201533221622425664400
   PubMed Web of Science ®Google Scholar
• NobiliAGarattiniSMannucciPMMultiple diseases and polypharmacy in the elderly: challenges for the internist of the third millenniumJ Comorb20111284429090134
   PubMedGoogle Scholar
• BassiPUOsakweAIOgarCKImpact of comorbidity on adverse drug reaction profile in a cohort of patients treated with artemisinin combination therapies for uncomplicated malaria in NigeriaPharmacol Res Perspect201752e0030228357128
   PubMed Web of Science ®Google Scholar
• Da CostaFASilvestreLPeriquitoCDrug-related problems identified in a sample of Portuguese institutionalised elderly patients and pharmacists’ interventions to improve safety and effectiveness of medicinesDrugs Real World Outcomes201631899727747806
   PubMedGoogle Scholar
• Garcia-CaballosMRamos-DiazFJimenez-MoleonJJBueno-CavanillasADrug-related problems in older people after hospital discharge and interventions to reduce themAge Ageing201039443043820497947
   PubMed Web of Science ®Google Scholar
• MaherRLHanlonJTHajjarERClinical consequences of polypharmacy in elderlyExpert Opinion On Drug Safety201413110
   Web of Science ®Google Scholar
• ZelkoEKlemenc-KetisZTusek-BuncKMedication adherence in elderly with polypharmacy living at home: a systematic review of existing studiesMater Sociomed201628212913227147920
   PubMedGoogle Scholar
• DumbreckSFlynnANairnMDrug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelinesBMJ2015350h94925762567
   PubMed Web of Science ®Google Scholar
• ZhangWOuyangHDassCRXuJCurrent research on pharmacologic and regenerative therapies for osteoarthritisBone Res201641504026962464
   PubMed Web of Science ®Google Scholar
• LabaTLBrienJAFransenMJanSPatient preferences for adherence to treatment for osteoarthritis: the medication decisions in osteoarthritis study (MEDOS)BMC Musculoskelet Disord201314116023647688
   PubMed Web of Science ®Google Scholar
• KovačevićSVMiljkovićBĆulafićMEvaluation of drug-related problems in older polypharmacy primary care patientsJ Eval Clin Pract201723486086528370742
   PubMed Web of Science ®Google Scholar
• AbuRBashetiIAbuHAlsalehAAburuzSAssessment of drug-related problems and their impact on blood pressure control in patients with hypertensionEur J Hosp Pharm2015233995
   Google Scholar
• WangYCHsiehTCChouCLWuJLFangTCRisks of adverse events following coprescription of statins and calcium channel blockers: a nationwide population-based studyMedicine2016952e248726765458
   PubMed Web of Science ®Google Scholar
• HusseinMLenjisaJLWolduMAAssessment of drug related problems among hypertensive patients on follow up in adama hospital medical college, East EthiopiaClin Pharmacol Biopharm201432122
   Google Scholar
• Zaman HuriHChai LingLDrug-related problems in type 2 diabetes mellitus patients with dyslipidemiaBMC Public Health2013131119224341672
   PubMed Web of Science ®Google Scholar
• Quintana-BárcenaPLordALizotteABerbicheDLalondeLPrevalence and management of drug-related problems in chronic kidney disease patients by severity level: a subanalysis of a cluster randomized controlled trial in community pharmaciesJ Manag Care Spec Pharm201824217318129384023
   PubMed Web of Science ®Google Scholar
• HestyUDrug-related problems in chronic kidney disease patients in an Indonesian HospitalInt J Pharm Pharm Sci2016128298302
   Google Scholar